Business Wire

AGCO iVenture Summit Calls for Venture Capital to Invest into the Future of Agriculture

Del

AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and solutions, today held its first ever AGCO iVenture Summit in Berlin, Germany. The Summit is a joint initiative of AGCO, AGCO Finance, AGCO’s Fuse Technologies, and Anterra Capital, a venture capital investor focusing on companies in the food and agricultural sectors.

“Startups are disrupting traditional agriculture and address many of the world’s most significant challenges, including food security, farmer livelihood and resource efficiency,” said Martin Richenhagen, AGCO Chairman, President and CEO. “Today, we are bringing Silicon Valley to Berlin. Agri-tech startups will pitch ideas that make a real difference and stand for technological progress and innovation in agriculture.”

The AGCO iVenture Summit targets innovators and visionaries who actively shape the future of agriculture by creating disruptive solutions that have the potential to move global agriculture forward. The purpose of the event is to strengthen the innovation culture in the agricultural community. The AGCO iVenture Summit strives to help innovators gain access to industry thought leaders, partners, and funding to ultimately help them bring new technologies to the market. The objective is to bring the right people together and build successful partnerships for a bright future and contribute to global food security.

Adam Anders, Managing Partner and co-founder of Anterra Capital, explained, “Entrepreneurs and venture capitalists are increasingly recognizing the long-term opportunity in the agricultural sector and are increasingly investing in agri-tech startups. At Anterra Capital, we invest across the food supply chain in technology driven companies and support them with capital, specialist knowledge and a network that extends beyond both the traditional agriculture community and the traditional venture capital community. For us the AGCO iVenture Summit is a unique platform to bring food and agriculture sector business leaders together with the best agri-tech startups and the strongest venture capital investors interested in this sector.”

Pioneering agri-tech entrepreneurs focus on innovative ideas along the agricultural value chain ranging from big data, cloud software, and robotics to new crops development, irrigation solutions, smart fertilizing, urban farming, and many others. Their disruptive technologies and novel solutions have the potential to make modern agriculture more productive, efficient, and sustainable. Today’s event provided a platform for revolutionary agri-tech startups to showcase their business models.

Participants at the AGCO iVenture Summit discussed the many ways in which agri-tech startups and venture capitalists could work together to develop novel technologies that increase agricultural productivity and create a better and more sustainable food security.

Guest speakers included Prof. Klaus Josef Lutz (CEO of BayWa AG), Bernard Krone (Managing Director and Owner, Bernard Krone Holding SE & Co. KG), Adrian Percy (Head of Research & Development, Crop Science – a division of Bayer), David Batcheller (Chairman of Appareo Systems, LLC), Berry Marttin (Member of the Managing Board, Rabobank), Michael Horsch (Founder, HORSCH Maschinen GmbH), and Prof. Dr. Thomas Herlitzius (Chair of Professorship for Agricultural Systems Technology, TU Dresden).

“The AGCO iVenture Summit provided a great platform for agri-tech startups like Agriconomie, Ecrorobotics, Farmobile, German Autolabs, TellusLabs, UseMyTec, and Wefarm and allowed them to connect with experts and build new relationships to grow their business ventures,” Richenhagen concluded. “At AGCO, we are always on the lookout for new ideas and the iVenture Summit introduced us to some amazing new technologies that are certainly interesting for us.”

For more information, please visit http://www.agco-iventure-summit.com/home.html

About AGCO

AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural solutions and supports more productive farming through its full line of equipment and related services. AGCO products are sold through five core brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra®, supported by Fuse® precision technologies and farm optimization services, and are distributed globally through a combination of over 3,000 independent dealers and distributors in more than 150 countries. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2016, AGCO had net sales of approximately $7.4 billion. For more information, visit http://www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.

Contact information

AGCO
Ulrich Stockheim
Chief Communications Officer
Ulrich.Stockheim@agcocorp.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00Pressemelding

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26Pressemelding

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05Pressemelding

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03Pressemelding

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and